SMT202400427T1 - Nuovo uso dell'agonista del recettore dell'angiotensina ii di tipo 2 - Google Patents

Nuovo uso dell'agonista del recettore dell'angiotensina ii di tipo 2

Info

Publication number
SMT202400427T1
SMT202400427T1 SM20240427T SMT202400427T SMT202400427T1 SM T202400427 T1 SMT202400427 T1 SM T202400427T1 SM 20240427 T SM20240427 T SM 20240427T SM T202400427 T SMT202400427 T SM T202400427T SM T202400427 T1 SMT202400427 T1 SM T202400427T1
Authority
SM
San Marino
Prior art keywords
angiotensin
type
receptor agonist
new use
new
Prior art date
Application number
SM20240427T
Other languages
English (en)
Italian (it)
Inventor
Carl-Johan Dalsgaard
Johan Raud
Rohit Batta
Original Assignee
Vicore Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2004209.9A external-priority patent/GB202004209D0/en
Priority claimed from GBGB2009574.1A external-priority patent/GB202009574D0/en
Application filed by Vicore Pharma Ab filed Critical Vicore Pharma Ab
Publication of SMT202400427T1 publication Critical patent/SMT202400427T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM20240427T 2020-03-23 2021-03-22 Nuovo uso dell'agonista del recettore dell'angiotensina ii di tipo 2 SMT202400427T1 (it)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2004209.9A GB202004209D0 (en) 2020-03-23 2020-03-23 New use
GBGB2009574.1A GB202009574D0 (en) 2020-06-23 2020-06-23 New use
US17/113,416 US11123329B1 (en) 2020-03-23 2020-12-07 Use of angiotensin II type 2 receptor agonist
PCT/GB2021/050699 WO2021191592A1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist
EP21715306.3A EP4125881B1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist

Publications (1)

Publication Number Publication Date
SMT202400427T1 true SMT202400427T1 (it) 2024-11-15

Family

ID=77747178

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20240427T SMT202400427T1 (it) 2020-03-23 2021-03-22 Nuovo uso dell'agonista del recettore dell'angiotensina ii di tipo 2

Country Status (12)

Country Link
US (2) US11123329B1 (cg-RX-API-DMAC7.html)
EP (1) EP4125881B1 (cg-RX-API-DMAC7.html)
JP (1) JP7671305B2 (cg-RX-API-DMAC7.html)
CN (1) CN115605201A (cg-RX-API-DMAC7.html)
CA (1) CA3176108A1 (cg-RX-API-DMAC7.html)
ES (1) ES2992423T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241435T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068662T2 (cg-RX-API-DMAC7.html)
PL (1) PL4125881T3 (cg-RX-API-DMAC7.html)
RS (1) RS66072B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400427T1 (cg-RX-API-DMAC7.html)
WO (1) WO2021191592A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004094D0 (en) * 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
US20220233480A1 (en) * 2020-03-23 2022-07-28 Vicore Pharma Ab Use of angiotensin ii type 2 receptor agonist
JP7798791B2 (ja) * 2020-04-22 2026-01-14 エアウェイ・セラピューティクス・インコーポレイテッド ウイルス感染症の治療のための肺サーファクタントタンパク質dの使用
CN117209555B (zh) * 2021-09-30 2024-12-03 中国科学院上海药物研究所 一类氰基化合物、其制备方法及用途
CN115583984A (zh) * 2022-01-11 2023-01-10 嘉兴安谛康生物科技有限公司 氮杂螺类化合物及其制备方法、药物组合物和用途
CN114948950A (zh) * 2022-01-19 2022-08-30 广州谷森制药有限公司 一种药物组合物及其抗病毒用途
TW202432112A (zh) * 2023-01-16 2024-08-16 大陸商海南先聲藥業有限公司 抗病毒藥物組合物及其製備方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
EP1723962A1 (en) 2005-05-19 2006-11-22 IMBA-Institut für Molekulare Biotechnologie GmbH Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries
HK1244232A1 (zh) 2015-03-02 2018-08-03 维科尔药物公司 用於治疗肺纤维化的血管紧张素ii受体激动剂
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition

Also Published As

Publication number Publication date
HUE068662T2 (hu) 2025-01-28
JP7671305B2 (ja) 2025-05-01
HRP20241435T1 (hr) 2024-12-20
CN115605201A (zh) 2023-01-13
WO2021191592A1 (en) 2021-09-30
ES2992423T3 (es) 2024-12-12
PL4125881T3 (pl) 2024-12-02
US11123329B1 (en) 2021-09-21
EP4125881B1 (en) 2024-07-24
CA3176108A1 (en) 2021-09-30
RS66072B1 (sr) 2024-11-29
EP4125881A1 (en) 2023-02-08
US20210386712A1 (en) 2021-12-16
JP2023520323A (ja) 2023-05-17
EP4125881C0 (en) 2024-07-24
US20210290596A1 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
HUE068662T2 (hu) Angiotenzin-ii-receptor-2 agonista új alkalmazása
PT4212527T (pt) Composto agonista do recetor glp-1r e suas utilizações
IL324507A (en) Thr-beta receptor agonist compound and method for its preparation and use
LT3989972T (lt) Į gliukagoną panašaus peptido 1 receptoriaus agonistai
PL4058445T3 (pl) Agonista receptora glp‑1 i jego zastosowanie
GB2603330B (en) Heterocyclic THR-B receptor agonist compound and preparation method and use therefor
ZA202006115B (en) Phenylpyrrolidinone formyl peptide 2 receptor agonists
IL281393A (en) Formulations for oral administration of kappa opioid receptor agonists
IL290479B2 (en) Non-peptide somatostatin receptor type 5 agonists and their use
TN2010000004A1 (en) Synergistic combinations of vr-1 antagonists and cox -2 inhibitors
IL304329A (en) Use of a melanocortin-4 receptor agonist
ZA202006157B (en) Pharmaceutical composition of kor receptor agonist
EP4091623A4 (en) CALCIUM SENSING RECEPTOR AGONIST COMPOUND AND ITS APPLICATION
EP3952852A4 (en) PROPHYLACTIC EFFECTIVENESS OF SEROTONIN-4 RECEPTOR AGONISTS AGAINST STRESS
IL315279A (en) Selective G protein-coupled receptor kinase 5 inhibitors, compositions and methods of use
EP3549948A4 (en) AGONISTIC PEPTIDE FOR ADIPONECTIN RECEPTOR
IL291502A (en) agonist for tacr2
AU2021349680A9 (en) Use of sphingosine-1-phosphate receptor agonist
EP3851106A4 (en) MEDICAL USES OF PROSTACYCLIN RECEPTORAGONISTS
IL326685A (en) Kappa opioid receptor antagonists
GB202108483D0 (en) Modulator of g protein-coupled receptor 88
GB201909004D0 (en) Prostaglandin EP4 receptor agonist compounds
GB201700238D0 (en) Prodrugs of an angiotensin receptor agonist